Home LiteratureArticle Details
PMID: 11350924 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

The EMBO journal ·Vol. 20 ·No. 10 ·2001-05-15 ·Pages 2357-66

Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL

Abstract

Protein degradation by proteasomes is the source of most antigenic peptides presented on MHC class I molecules. To determine whether proteasomes generate these peptides directly or longer precursors, we developed new methods to measure the efficiency with which 26S and 20S particles, during degradation of a protein, generate the presented epitope or potential precursors. Breakdown of ovalbumin by the 26S and 20S proteasomes yielded the immunodominant peptide SIINFEKL, but produced primarily variants containing 1-7 additional N-terminal residues. Only 6-8% of the times that ovalbumin molecules were digested was a SIINFEKL or an N-extended version produced. Surprisingly, immunoproteasomes which contain the interferon-gamma-induced beta-subunits and are more efficient in antigen presentation, produced no more SIINFEKL than proteasomes. However, the immunoproteasomes released 2-4 times more of certain N-extended versions. These observations show that the changes in cleavage specificity of immunoproteasomes influence not only the C-terminus, but also the N-terminus of potential antigenic peptides, and suggest that most MHC-presented peptides result from N-terminal trimming of larger proteasome products by aminopeptidases (e.g. the interferon-gamma-induced enzyme leucine aminopeptidase).

Keywords
Non-programmatic
MeSH Terms
Animals Antigens/biosynthesis,immunology Egg Proteins/biosynthesis,immunology Epitopes, B-Lymphocyte/biosynthesis,immunology Hybridomas Immunodominant Epitopes/biosynthesis,immunology Mice Ovalbumin/biosynthesis,immunology Peptide Biosynthesis Peptide Fragments Peptide Hydrolases/metabolism Peptides/immunology Proteasome Endopeptidase Complex
Chemicals
Antigens Egg Proteins Epitopes, B-Lymphocyte Immunodominant Epitopes OVA-8 Peptide Fragments Peptides Ovalbumin Peptide Hydrolases Proteasome Endopeptidase Complex ATP dependent 26S protease
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Cascio P
Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Hilton C
Kisselev A F
Rock K L
Goldberg A L
References (42)
42 references, click to expand
  1. Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.
    J Exp Med. 1999 Nov 1;190(9):1227-40 PMID: 10544195
  2. Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER.
    Immunity. 1999 Aug;11(2):241-51 PMID: 10485659
  3. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens.
    Immunol Rev. 1999 Dec;172:29-48 PMID: 10631935
  4. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    J Exp Med. 2000 Jan 17;191(2):239-52 PMID: 10637269
  5. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
    J Exp Med. 2000 Feb 7;191(3):503-14 PMID: 10662796
  6. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
    J Immunol. 2000 Apr 15;164(8):4003-10 PMID: 10754291
  7. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.
    Nature. 2000 Apr 13;404(6779):770-4 PMID: 10783891
  8. The major substrates for TAP in vivo are derived from newly synthesized proteins.
    Nature. 2000 Apr 13;404(6779):774-8 PMID: 10783892
  9. A proteasome howdunit: the case of the missing signal.
    Cell. 2000 May 12;101(4):341-4 PMID: 10830160
  10. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    J Immunol. 2000 Jul 15;165(2):768-78 PMID: 10878350
  11. Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination.
    J Biol Chem. 2000 Jul 7;275(27):20295-301 PMID: 10791958
  12. The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate.
    J Biol Chem. 2000 Jul 14;275(28):21140-8 PMID: 10801794
  13. PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone.
    Nat Cell Biol. 2000 Nov;2(11):833-9 PMID: 11056539
  14. Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum.
    J Immunol. 2001 Mar 15;166(6):3952-6 PMID: 11238640
  15. Two new proteases in the MHC class I processing pathway.
    Nat Immunol. 2000 Nov;1(5):413-8 PMID: 11062501
  16. Generation of class I MHC-restricted T-T hybridomas.
    J Immunol. 1990 Aug 1;145(3):804-11 PMID: 2115542
  17. Cellular peptide composition governed by major histocompatibility complex class I molecules.
    Nature. 1990 Nov 15;348(6298):248-51 PMID: 2234092
  18. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation.
    Nature. 1993 Jun 10;363(6429):552-4 PMID: 8389422
  19. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
    Nature. 1993 Sep 16;365(6443):264-7 PMID: 8396732
  20. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides.
    J Immunol. 1994 Apr 15;152(8):3884-94 PMID: 8144958
  21. Peptide size selection by the major histocompatibility complex-encoded peptide transporter.
    J Exp Med. 1994 May 1;179(5):1613-23 PMID: 8163941
  22. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Cell. 1994 Sep 9;78(5):761-71 PMID: 8087844
  23. Trimming of antigenic peptides in an early secretory compartment.
    J Exp Med. 1994 Dec 1;180(6):2389-94 PMID: 7964513
  24. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
    Immunity. 1995 Mar;2(3):289-99 PMID: 7535183
  25. Altered peptidase and viral-specific T cell response in LMP2 mutant mice.
    Immunity. 1994 Oct;1(7):533-41 PMID: 7600282
  26. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.
    J Biol Chem. 1995 Oct 6;270(40):23808-15 PMID: 7559557
  27. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
    J Immunol. 1996 Jul 15;157(2):617-24 PMID: 8752909
  28. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum.
    J Biol Chem. 1997 Jan 17;272(3):1791-8 PMID: 8999862
  29. Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity.
    J Biol Chem. 1997 May 2;272(18):11824-31 PMID: 9115240
  30. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10850-5 PMID: 9380723
  31. Mechanisms of MHC class I--restricted antigen processing.
    Annu Rev Immunol. 1998;16:323-58 PMID: 9597133
  32. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome".
    J Biol Chem. 1998 Jul 3;273(27):16764-70 PMID: 9642232
  33. Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase.
    J Biol Chem. 1998 Jul 24;273(30):18734-42 PMID: 9668046
  34. The making of the dominant MHC class I ligand SYFPEITHI.
    Eur J Immunol. 1998 Aug;28(8):2478-86 PMID: 9710225
  35. Decelerated degradation of short peptides by the 20S proteasome.
    FEBS Lett. 1998 Sep 4;434(3):357-61 PMID: 9742954
  36. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities.
    Eur J Immunol. 1998 Dec;28(12):4029-36 PMID: 9862339
  37. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation.
    J Biol Chem. 1999 Feb 5;274(6):3363-71 PMID: 9920878
  38. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.
    Annu Rev Immunol. 1999;17:51-88 PMID: 10358753
  39. Degradation of cell proteins and the generation of MHC class I-presented peptides.
    Annu Rev Immunol. 1999;17:739-79 PMID: 10358773
  40. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    J Immunol. 1999 Jun 15;162(12):7075-9 PMID: 10358150
  41. 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate.
    J Biol Chem. 1999 Jul 30;274(31):21963-72 PMID: 10419519
  42. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    J Immunol. 1999 Dec 1;163(11):5851-9 PMID: 10570269
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2001-05-15
Pages
2357-66
Language
English
Region
England
NLM ID
8208664
PMCID
PMC125470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com